Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age12-20
SponsorChildren's Mercy Hospital Kansas City
About this trial
This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).
Eligibility criteria
Qualifiers
Diagnosis of Turner Syndrome and Primary Ovarian Insufficiency.
Prescribed adult dosing* of transdermal or oral estradiol for estrogen replacement therapy.
Have achieved menarche.
Disqualifiers
Disclosure of sexual activity and desire for contraception.
Having a levonorgestrel-releasing intrauterine device or etonogestrel arm implant in place.
Having received depot medroxyprogesterone within one year prior to study recruitment.
Non-English or non-Spanish speaking.
Trial design
Treatments tested in this trial
- Micronized progesterone 200 MG
- Micronized Progesterone 100 MG
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov